Children's Hospital Los Angeles

Dr. Maurice O’Gorman to Speak on AAAS Webinar about Immune System Monitoring to Combat COVID-19

Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET.

Newswise — Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET.  

He will be part of an expert panel of speakers that will also include Andrea Cossarizza, MD, PhD, Vice Dean of the School of Medicine at the University of Modena and Reggio Emilia in Italy, and President of the International Society for Advancement of Cytometry, and Lishomwa Ndhlovu, MBBS, PhD, a Professor of immunology at Weill Cornell Medicine in New York and Principal Investigator of the HIV and Emerging Pathogens Immunopathogenesis Laboratory. 

Dr. O’Gorman, Chief of Laboratory Medicine at CHLA and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. During this webinar, Dr. O’Gorman will discuss early results from labs around the world that have begun measuring CD4 and CD8 T-cell levels in peripheral blood as potential biomarkers for the prognosis of patients with COVID-19. 

Decreased CD4 and CD8 cells means more severe disease

Hospitals are observing that patients with severe cases of COVID-19 have significantly lower absolute numbers of CD4 and CD8 T-lymphocytes in their peripheral blood, compared to patients with mild or moderate disease. Low numbers of CD4 cells could potentially impact a patient’s ability to form antibodies against the virus, and low CD8 cells could diminish the patient’s ability to eliminate coronavirus from the body. 

Dr. O’Gorman will discuss the potential role for routine measurement of CD4 and CD8 T-cells—a process called immunophenotyping—in hospitalized COVID-19 patients participating in clinical trials. Immunophenotyping may provide a tool for prognostics stratification of disease, and potentially as a way to monitor response to treatment.


Register for webinar

Register for this Science/AAAS webinar here:

Filters close

Showing results

110 of 3446
Released: 29-Sep-2020 7:05 PM EDT
Research into SARS-CoV-2 mutation “hotspots” raises implications for vaccines and therapeutics
UCLA Fielding School of Public Health

Researchers have found at least 10 distinct “hotspot” mutations in more than 80% of randomly selected SAR-CoV-2 sequences from six countries, and these genome hotspots – seen as "typos" that can occur as the virus replicates during cellular division – could have a significant impact in the fight against the COVID-19 pandemic.

Newswise: New “Buzz” about Fighting COVID-19 at Baltimore-Area Barbershops
Released: 29-Sep-2020 6:30 PM EDT
New “Buzz” about Fighting COVID-19 at Baltimore-Area Barbershops
LifeBridge Health

LifeBridge Health Partners with Live Chair Health to Offer Coronavirus Support And Expansion of Barbershop Health Screening Program

access_time Embargo lifts in 2 days
Embargo will expire: 30-Sep-2020 7:05 PM EDT Released to reporters: 29-Sep-2020 5:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Sep-2020 7:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Eccles School Launches Postdoctoral Program in Entrepreneurship & Strategy
Released: 29-Sep-2020 4:45 PM EDT
Eccles School Launches Postdoctoral Program in Entrepreneurship & Strategy
University of Utah, David Eccles School of Business

The Department of Entrepreneurship & Strategy at the University of Utah’s David Eccles School of Business launched a new postdoctoral fellowship program with the hire of Maria Kurakina, a young scholar with a Ph.D. from the University of California at Berkeley, Haas School of Business.

Released: 29-Sep-2020 4:35 PM EDT
Study supports airborne spread of COVID-19 indoors
University of Georgia

New research from the University of Georgia supports growing evidence for airborne transmission of COVID-19 in enclosed spaces.

Newswise: 244300_web.jpg
Released: 29-Sep-2020 3:35 PM EDT
Conversation quickly spreads droplets inside buildings
Princeton University School of Engineering and Applied Science

With implications for the transmission of diseases like COVID-19, researchers have found that ordinary conversation creates a conical 'jet-like' airflow that quickly carries a spray of tiny droplets from a speaker's mouth across meters of an interior space.

Released: 29-Sep-2020 2:25 PM EDT
VirScan offers new insights into COVID-19 antibody response
Brigham and Women’s Hospital

A tool designed to detect viral history in a drop of blood has gotten an upgrade in the age of COVID-19.

Newswise: 244362_web.jpg
Released: 29-Sep-2020 1:50 PM EDT
In a field where smaller is better, researchers discover the world's tiniest antibodies
University of Bath

Researchers at the University of Bath in the UK and biopharma company UCB have found a way to produce miniaturised antibodies, opening the way for a potential new class of treatments for diseases.

Showing results

110 of 3446